Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BENZOCAINE ORAL TOP

Closed
SPE2DP-26-T-3376Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract pertains to the procurement of Benzoocaine Oral Topical Gel, specifically a 20% concentration in a 1-ounce (28-gram) tube, under the solicitation number SPE2DP-26-T-3376. This item is subject to detailed packaging and quality requirements as outlined by the Defense Logistics Agency (DLA), including adherence to the DLA Master List of Technical and Quality Requirements and Medical Marking Standard No. 1. The gel must have a non-extendable shelf life of 36 months and be packaged in sealed unit containers that protect against damage during shipment. The packaging must comply with commercial standards and ensure safe delivery to the destination within 20 days of order, with inspections and acceptance occurring at the destination. The contract designates Beutlich Pharmaceuticals, LLC as the supplier with a specific National Stock Number (6505-01-064-5769) and requires delivery FOB destination. The order quantity is one unit of issue (28 grams), and the procurement is managed by the Department of Defense's Medical Supply Chain Pharmacy FSA. The solicitation is open until May 18, 2026, and the contract requires compliance with packaging standards MIL-STD-2073-1E along with removal of government identification on non-accepted supplies. Communication for the contract is handled by Timothy McCauley at DLA, ensuring all technical and administrative processes meet federal acquisition regulations.

General Info

Procurement of 20% Benzoocaine Gel, 28g tube, DLA quality standards, delivery FOB, May 2026 deadline.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

100 MINUTEMAN DR, ASHEVILLE, NC, 28806-0000, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3376 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts

Full Description

Show more
BENZOCAINE ORAL TOP
BENZOCAINE ORAL TOPICAL GEL, 20%,1 OZ or (28G) RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
U/I "BT"
INCLUDE ZX001 OBJECT TEXT ID ST
1 BT = 28 GM
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
BEUTLICH PHARMACEUTICALS, LLC 34547 P/N NDC00283-0871-31
SPE2DP-26-T-3376
SECTION B
PR: 7016723703 PRLI: 0001 CONT’D
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016723703 0001 BT 1.000
NSN/MATERIAL:6505010645769
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-064-5769 Quantity: 1 BT Purchase Request: 7016723703QTY: 1 Delivery: 20 days ADO